Article

Evaluation of transferrin-polyethylenimine conjugate for targeted gene delivery.

College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Korea.
Archives of Pharmacal Research (Impact Factor: 1.54). 07/2005; 28(6):722-9. DOI: 10.1007/BF02969364
Source: PubMed

ABSTRACT With the aim to improve the specificity and to reduce the cytotoxicity of polyethylenimine (PEI), we have synthesized the conjugates of the branched PEI (25 kDa) with transferrin. The transferrin-PEI (TP) conjugates with five compositions were synthesized using periodate oxidation method and confirmed by FT-IR spectroscopy and gel permeation chromatography. The free amine contents of TP conjugates, which were able to condense and deliver DNA, increased as the amount of PEI increased. TP/DNA polyplexes were characterized by measuring gel electrophoresis, ethidium bromide fluorescence quenching, particle size and zeta potential of complexes. Complete complexation of the polyplexes was observed above the N/P ratio of 5 in TP/ DNA, and above 3 in PEI/DNA, respectively. The zeta potential of the complexes decreased as the amount of transferrin in TP conjugates increased. Transfection efficiency of TP conjugates was evaluated in HeLa cell and Jurkat cell systems. Among the five compositions of TP conjugates, TP-2 system mediated a higher beta-galactosidase gene expression than PEI system in Jurkat cell which was known to express elevated numbers of transferrin receptors. From the results of the cell viability based on MTT assay, TP conjugates showed lower cytotoxicity compared with the PEI system. We expect that the TP conjugate can be used efficiently as a nonviral gene delivery vector.

0 Bookmarks
 · 
84 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conjugation of various arginine-rich peptide sequences to vectors based on 10kDa polyethylenimine (PEI) and its hydrophobic derivative (hexanoate-PEI) was investigated as a strategy for improving pDNA and siRNA transfection activities. Six different arginine-histidine (RH) sequences and two arginine-serine (RS) sequences with a range of R/H ratios were designed and coupled to PEI and hexanoate-PEI. All arginine-rich peptide derivatives of PEI significantly enhanced luciferase gene expression compared to PEI 10kDa alone. Hexanoate-PEI derivatives exhibited higher transfection activity than underivatized PEI vectors. Improved transfection activity may have resulted at least in part from use of higher vector/DNA ratios made possible by reduced cytotoxicity of vectors, and to use of vectors with higher molecular weights. Vectors that were the most efficient in pDNA delivery and transfection were also the most effective in siRNA delivery and protein expression knock down.
    International journal of biological macromolecules 05/2013; · 2.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: One of the challenges currently facing neuroscientists is the development of effective therapies based on the advances achieved on basic research. The use of genes as pro-drugs can be faced as an approach to reduce this gap. Furthermore, gene downregulation through the use of antisense strategies, including the recent introduction of RNA interference, is yet another tool with great therapeutic potential. While viruses have proved to be the most efficient system to mediate the delivery of nucleic acids (mostly DNA), their use in a clinic scenario raises various safety concerns. Additionally, the regional specialization of the nervous system function dictates that a therapeutic intervention may be best achieved by the local and specific delivery of a therapeutic agent. In that sense a targeted delivery may avoid unwanted adverse effects that could result from a more ubiquitous delivery. In this chapter, the alternative strategies being explored to the delivery of nucleic acids (DNA, antisense and siRNA oligonucleotides) to the nervous system will be discussed, with particular focus on biomaterial-based systems.
    Drug Delivery Systems: Advanced Technologies Potentially Applicable in Personalised Treatment, 1st edited by Jorge Coelho, 01/2013: pages 185-224; Springer Netherlands., ISBN: 978-94-007-6010-3
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lack of safe, efficient and controllable methods for delivering therapeutic genes appears to be the most important factor preventing human gene therapy. Safety issues encountered with viral vectors have prompted substantial attention to in vivo investigations with non-viral vectors throughout the past decade. However, developing non-viral vectors with effectiveness comparable to viral ones has been a challenge. The strategy of designing multifunctional synthetic carriers targeting several extra- and intracellular barriers in the gene transfer pathway has emerged as a promising approach to improving the efficacy of gene delivery systems. This review will explain how sophisticated synthetic vectors can be created by combining conventional polycationic vectors such as polyethylenimine and basic amino acid peptides with additional polymers and peptides that are designed to overcome potential barriers to the gene delivery process.
    International Journal of Pharmaceutics 09/2013; · 3.99 Impact Factor